Les Meilleurs doctors pour le traitement de cancer du colon en Israël - TOP-24 des médecins

Le Dr Pelles Sharon a été formée au Royal Marsden – le premier centre de cancérologie d'Europe – en se spécialisant dans les cancers gastro-intestinaux. Elle dirige l'Institut des tumeurs du système digestif à Ichilov.

• Être experte en HIPEC et en thérapies ciblées du cancer colorectal
• Enseigner à la faculté de médecine de l'université de Tel Aviv
• Être chercheuse publiée sur les traitements de l'adénocarcinome pancréatique
• Être membre de l'Association israélienne d'oncologie et de radiologie

Le professeur Ofer Merimsky dirige l'unité d'oncologie des tissus mous et des os au centre médical Sourasky – l'un des meilleurs hôpitaux de cancérologie d'Israël.

• Plus de 30 ans de spécialisation dans les sarcomes et les cas de tumeurs complexes
• Formation spécialisée (Fellowship) à l'Institut Gustave Roussy, premier centre de lutte contre le cancer en Europe
• Membre de la faculté de l'ESMO pour les protocoles de traitement des sarcomes
• Publier des recherches approfondies sur les thérapies innovantes contre le cancer

Le professeur Nadir Arber dirige l'un des rares centres de prévention du cancer en Israël, se consacrant exclusivement à l'arrêt du cancer avant qu'il ne commence.

• Plus de 30 ans d'expérience dans le traitement des tumeurs de l'appareil gastro-intestinal
• Auteur de plus de 300 articles scientifiques sur la prévention du cancer et la thérapie génique
• Diriger le centre intégré de prévention du cancer au centre médical Sourasky de Tel Aviv
• Être membre des principales associations internationales d'oncologie et de gastro-entérologie
• Réaliser des travaux de recherche au prestigieux NewYork-Presbyterian Center

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Le professeur Ido Wolf dirige l'ensemble du département d'oncologie du centre médical de Tel Aviv, l'un des principaux hôpitaux d'Israël. Il possède une expérience spécifique dans le traitement des tumeurs colorectales et du foie.

• Diriger la division d'oncologie médicale au centre médical Sourasky (Ichilov)
• Posséder plus de 20 ans d'expérience en oncologie et en médecine interne
• Formation médicale à la prestigieuse faculté de médecine Sackler de l'université de Tel Aviv
• Se spécialiser dans le diagnostic complexe et la prise en charge des cancers gastro-intestinaux

Le professeur Tulchinsky est directeur de l'unité de chirurgie du côlon et du rectum et chef de la division de chirurgie générale au centre médical Sourasky de Tel Aviv.

• Expert de premier plan dans les maladies colorectales et anales, y compris le cancer
• Réaliser des chirurgies restauratrices pour le cancer du rectum et les pathologies familiales
• Se spécialiser dans les résections intestinales laparoscopiques mini-invasives
• L'unité est leader dans les procédures colorectales diagnostiques et thérapeutiques

Directeur de l'hospitalisation oncologique au centre médical de Tel Aviv, Ichilov – Le Dr Stepfansky a plus de 20 ans d'expérience en oncologie.

• Spécialisé en oncologie au centre médical de Tel Aviv
• Chercheur principal dans des études d'oncologie clinique
• Certifié en médecine interne et en oncologie
• Reconnu pour les cas complexes de cancer du côlon

Dirige le service de chirurgie colorectale du centre médical Sourasky – un spécialiste de premier plan avec plus de 20 ans d'expérience chirurgicale.

• Expert en techniques chirurgicales ouvertes et mini-invasives
• Réaliser des procédures complexes telles que la chirurgie de Whipple
• Se concentrer exclusivement sur la chirurgie abdominale et colorectale

Un spécialiste exclusivement dédié à la chirurgie du cancer du côlon, fort de plus de 25 ans de pratique académique et clinique. Il est le directeur du programme de résidence en chirurgie au centre médical Hadassah.

• Certifié par le conseil israélien en chirurgie générale depuis 1998
• Instructeur, conférencier et maître de conférences en chirurgie depuis des décennies
• Membre de plusieurs associations chirurgicales reconnues
• Maîtrise de l'anglais et de l'hébreu pour la communication avec les patients

Le Dr Auala Hubert dirige le Centre des cancers gastro-intestinaux du centre médical Hadassah, spécialisé dans le cancer du côlon.

• Avoir 33 ans d'expérience en oncologie et en radiothérapie
• Détenir des certifications de spécialisation en oncologie et en radiothérapie
• Exercer en tant que médecin titulaire à l'hôpital universitaire Hadassah
• Être membre du comité pour les cancers gastro-intestinaux en Israël
• Suivre une formation médicale au prestigieux hôpital universitaire Hadassah

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Chef adjoint du département d'oncologie – un rôle de direction de haut niveau supervisant les soins oncologiques complexes au centre médical Rambam.

• Se spécialiser dans le traitement des patients atteints de cancer du côlon
• Travailler à Rambam – un hôpital tertiaire de premier plan en Israël
• Occuper un poste de direction pour guider les protocoles de traitement et la recherche

Le Dr Alexander Beny dirige le service des tumeurs malignes gastro-intestinales au centre médical Rambam, apportant des décennies d'expertise ciblée sur le cancer du côlon.

• Titulaire de certifications européennes et israéliennes en oncologie
• Directeur du service des tumeurs malignes gastro-intestinales – spécialisé dans les cancers digestifs
• Dirige une clinique dédiée à l'oncologie gastro-intestinale
• Formation avancée achevée dans les techniques modernes de radiothérapie
• Médecin senior au département d'oncologie avec une vaste expérience clinique